Dr. Ludger Dinkelborg leads the Imaging Division of Piramal Enterprises. This section was created through the acquisition of worldwide rights for the Molecular Imaging Research and Development Portfolio of Bayer Pharma AG.
Before co-founding Piramal Imaging, Dr. Ludger served as Head of Diagnostic Imaging Research and Head of Molecular Imaging at Bayer HealthCare. He has more than 20 years of R&D experience in the pharmaceutical industry.
He received his PhD in Biology at Heinrich-Heine-University, Düsseldorf, and continued as guest researcher at the Max-Planck-Institute for Molecular Physiology in Dortmund. He became a fellow of the Konrad-Adenauer-Foundation, attended the Cranfield Schering University course for managers and also attended the Executive Program at Stanford School of Business, CA.
Chairman, Piramal Group
Executive Director, Piramal Enterprises Ltd.
Executive Director, Piramal Enterprises
Director, Piramal Glass
Chairman, Piramal Glass Ceylon Plc.
Managing Director, Piramal Finance Ltd.
Managing Director, Piramal Housing Finance Ltd
CEO, Pharma Solutions, Piramal Enterprises Ltd
President & Chief Operating Officer - Consumer Products, Piramal Enterprises Ltd.
IT Head, Piramal Group
CEO, Critical Care, Piramal Enterprises Ltd.
Group Director - Strategic Business
CEO, Decision Resources Group
Managing Director, India Resurgence Fund (India RF)
Executive Director, Piramal Group
Executive Director, Piramal Housing Finance Ltd
CEO, Piramal Foundation
Group General Counsel, Piramal Group
President & Chief Human Resources Officer, Piramal Enterprises Limited